Philadelphia health providers and patients seek a new treatment roadmap for sickle cell disease after drug recall
Scott Peslak of the Perelman School of Medicine says that the overall goal is always to keep patients safe while providing care, even if it means recalling a drug that has been on the market for several years.
・ From WHYY (Philadelphia)